C 217 Pill - green capsule/oblong
Pill with imprint C 217 is Green, Capsule/Oblong and has been identified as Risperidone 4 mg. It is supplied by Caraco Pharmaceutical Laboratories, Ltd.
Risperidone is used in the treatment of Autism; Asperger Syndrome; Schizoaffective Disorder; Bipolar Disorder; Schizophrenia and belongs to the drug class atypical antipsychotics. Risk cannot be ruled out during pregnancy. Risperidone 4 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for C 217
Risperidone
- Imprint
- C 217
- Strength
- 4 mg
- Color
- Green
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Atypical antipsychotics
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Caraco Pharmaceutical Laboratories, Ltd.
- National Drug Code (NDC)
- 57664-0217 (Discontinued)
- Inactive Ingredients
-
lactose,
microcrystalline cellulose,
hypromelloses,
corn starch,
silicon dioxide,
sodium lauryl sulfate,
magnesium stearate,
propylene glycol,
D&C Green No. 5,
magnesium silicate,
titanium dioxide,
FD&C Blue No. 2,
D&C Yellow No. 10
Note: Inactive ingredients may vary.
Related images for "C 217"
More about risperidone
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (721)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: atypical antipsychotics
- Breastfeeding
Patient resources
- Risperidone drug information
- Risperidone injection
- Risperidone (Intramuscular, Subcutaneous) (Advanced Reading)
- Risperidone (Oral) (Advanced Reading)
- Risperidone Tablets
Other brands
Risperdal, Uzedy, Risperdal Consta, Perseris, ... +3 more
Professional resources
- Risperidone monograph
- Risperidone (FDA)
- Risperidone Oral Solution (FDA)
- Risperidone Orally Disintegrating (FDA)
Other brands
Risperdal, Uzedy, Risperdal Consta, Perseris, Rykindo
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
